| Filed On | Filing |
|---|---|
| 03 Sep 2026 |
Form 4: Sanzone Virginia Ruth, VP, General Counsel
Sold 4,856 shares ($819K) |
| 03 Sep 2026 | 144 |
| 01 Sep 2026 |
Form 4: Bonnell Brian Michael, Chief Financial Officer
Sold 6,381 shares ($1.12M) |
| 01 Sep 2026 | 144 |
| 31 Aug 2026 |
Form 4: Bonnell Brian Michael, Chief Financial Officer
Sold 9,307 shares ($1.61M) |
| 31 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 |
Form 4: Woolson Daniel, VP, GM-Infusion Capital
Sold 5,417 shares ($982K) |
| 13 Aug 2026 | 144 |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 |
Form 4: Sousa Ben, Chief Information Officer
Sold 2,250 shares ($401K) |
| 12 Aug 2026 | 144 |
| 11 Aug 2026 |
Form 4: Voigtlander Christian B., Chief Operating Officer
Sold 8,929 shares ($1.63M) |
| 11 Aug 2026 |
Form 4: Finney Elisha W, Director
Sold 378 shares ($69K) |
| 11 Aug 2026 | 144 |
| 11 Aug 2026 | 144 |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 01 Jun 2026 | SD |
| 22 May 2026 | 144 |
Loading...
